Kimialys develops and sells proprietary and patented surface chemistry for biosensors.
Kimialys has raised $4.2M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
Kimialys's investors include AGORANOV, Octalfa, Relyens, Evolem Start, Angels Santé.
Kimialys is headquartered in Paris, France.
Kimialys develops and sells proprietary and patented surface chemistry for biosensors.
Kimialys is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kimialys — Funding & Investors." VCBacked, December 5, 2025, https://www.vcbacked.co/company/kimialys. Accessed September 11, 2026.
VCBacked. (2025). Kimialys — Funding & Investors. Retrieved September 11, 2026, from https://www.vcbacked.co/company/kimialys
{{cite web |title=Kimialys — Funding & Investors |url=https://www.vcbacked.co/company/kimialys |website=VCBacked |access-date=September 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated